04/02/2021
Australia's COVID-19 Vaccine Information
Vaccination Information:
The vaccine requires two doses to ensure maximum effectiveness, with the second dose provided 3 weeks after the first. Vaccines will be administered at more than 1000 points across Australia, with no charge to the patient.
Vaccination Testing & Approval Information:
To ensure the vaccine being provided is effective and safe, multiple levels of testing and approval have to be undergone. Testing and approval occur in the following stages:
- Testing phase 1: clinical trials on a few dozen healthy adult volunteers to ensure safety and active immune response.
- Testing phase 2: clinical trials on hundreds of volunteers varying in demographic (age, health, medical conditions) to ensure safety and immune response, whilst monitoring side effects.
- Testing phase 3: clinical trials on thousands of volunteers to ensure safety and immune response, monitoring side effects, and studying the effectiveness against placebo groups.
- Approval phase: Therapeutic Goods Administration (TGA) assessment and approval.
Vaccine National Roll-out Strategy:
Australia will begin population vaccination with the COVID-19 vaccine beginning in February, and continuing over the following months. Vaccinations will be provided on a priority basis to ensure high-risk individuals are protected as early as possible.
Vaccinations will be provided in in 3 broad phases, encompassing a total of 5 sub-phases:
Phase 1a: up to 1.4m vaccines will be provided to:
- Quarantine and border workers (70,000)
- Frontline health care workers (100,000)
- Aged care and disability care staff (318,000)
- Aged care and disability care residents (190,000)
Phase 1b: up to 14.8m vaccines will be provided to:
- Adults aged 80 years and over (1,045,000)
- Adults aged 70 years and over (1,858,000)
- Other health care workers
- Aboriginal and Torres Strait Islander people aged 55 years and over (87,000)
- Adults with a medical condition or disability
(2,000,000)
- Critical and high risk workers (196,000)
Phase 2a: up to 15.8m vaccines will be provided to:
- Adults aged 60 years and over (2,650,000)
- Adults aged 50 years and over (3,080,000)
- Aboriginal and Torres Straight Islander people aged 18 years and over (387,000)
- Other critical and high risk workers (435,000)
Phase 2b: up to 16m vaccines will be provided to:
- Balance of adult population (6,643,000)
Phase 3: up to 13.6m vaccines will provided to:
- Balance of population aged 18 years and under (if recommended) (5,670,00)
If you would like more information, speak to one of our friendly staff members.
Source: Department of Health, Australian Government. 2020. "Coronavirus (COVID-19)". Department of Health, Australian Government. Source: https://www.health.gov.au/
Information for the general public and the health and aged care workforce about the Australian Government's health policies, programs and regulations